|
Index of reports
> Cases resulting in other serious reactions (28)
> Cases with Bone Pain (3)
Below is the selection of adverse event reports related to Flexeril (Cyclobenzaprine) that includes cases resulting in other serious reactions where reactions include bone pain.
Adverse event in female receiving Flexeril (Cyclobenzaprine)
Reported by a consumer/non-health professional from United States on 2007-10-15
Patient: female
Adverse reactions / side effects: Tooth Fracture, Tooth Erosion, Bone Pain, Cardioactive Drug Level Decreased, Sensory Loss, Hypoaesthesia, Hepatic Enzyme Increased, High Density Lipoprotein Decreased, Device Failure, Tooth Discolouration, Blood Disorder, LOW Density Lipoprotein Increased, Tooth Disorder
Suspect drug(s):
Lipitor
Indication: Blood Cholesterol
Neurontin
Indication: Bone Pain
Neurontin
Indication: Complex Regional Pain Syndrome
Flexeril
Digitek
Warfarin Sodium
Other drugs received by patient: Toprol-XL; Toprol-XL; Klor-CON; Klor-CON; Synthroid; Synthroid; Klonopin; Klonopin; Wellbutrin XL; Wellbutrin XL; Welchol; Welchol; Combivent; Combivent; Omeprazole; Omeprazole; Folic Acid; Folic Acid; Zestril; Zestril; Lortab; Lortab; Xalatan; Xalatan; Diclofenac Sodium; Diclofenac Sodium; Pulmicort; Pulmicort; Duoneb; Duoneb; Theophylline; Theophylline; Lasix; Lasix; Lidoderm; Lidoderm
Adverse event in 79 year old female receiving Flexeril (Cyclobenzaprine)
Reported by a individual with unspecified qualification from United States on 2007-07-13
Patient: 79 year old female
Adverse reactions / side effects: Hot Flush, Bone Pain, Dyskinesia, Drug Interaction, Injury, Convulsion
Suspect drug(s):
Femara
Dosage: 2.5 mg, qd
Administration route: Oral
Indication: Breast Cancer
Start date: 2006-01-01
Flexeril
Indication: Injury
Start date: 2007-01-22
End date: 2007-01-22
Adverse event in 79 year old female receiving Flexeril (Cyclobenzaprine)
Reported by a consumer/non-health professional from United States on 2007-02-19
Patient: 79 year old female
Adverse reactions / side effects: Hot Flush, Bone Pain, Dyskinesia, Drug Interaction, Injury, Convulsion
Suspect drug(s):
Femara
Dosage: 2.5 mg, qd
Administration route: Oral
Indication: Breast Cancer
Start date: 2006-01-01
Flexeril
Indication: Injury
Start date: 2007-01-22
End date: 2007-01-22
|
